Khushbu Patel, PhD
Assistant Professor of Clinical Pathology and Laboratory Medicine
Perelman School of Medicine at the University of Pennsylvania
Director, Clinical Chemistry Lab and Point-of-Care, Children's Hospital of Philadelphia
Specialty Division
Laboratory Medicine
Education
B.S. (Biochemistry), Pennsylvania State University, 2007
Ph.D. (Molecular Cell Biology), Washington University, 2014
Specialty Certification
American Board of Clinical Chemistry, 2016
Postgraduate Training
Fellowship, Clinical Chemistry, Washington University School of Medicine, 2014-2016
Awards and Honors
Merck Summer Research Scholar
Pennsylvania State University, University Park, Pa, 2006
Markey Scholar, Special Emphasis Pathway in Human Pathobiology
Washington University School of Medicine, St. Louis, MO, 2008
Honorable Mention - Graduate Research Fellowship
National Science Foundation, St. Louis, MO, 2009
Research/Travel Award
FASEB Gastrointestinal Research Conference, Steamboat Springs, CO, 2011
Richard Marshall Education Award for Excellence in Research
AACC Midwest Section, St. Louis, MO, 2015
Outstanding Speaker Award
AACC Annual Meeting, Philadelphia, PA, 2016
2nd Place Student Poster Competition
AACC Annual Meeting, Philadelphia, PA, 2016
Fellow
AACC Academy, Washington, DC, 2017
General Research Grant Award
AACC, Washington, DC, 2018
Early Career Investigator Award
Children's Clinical Research Advisory Committee
Children's Health Dallas, Dallas, TX, 2018
Memberships and Professional Organizations
American Association of Clinical Chemistry (AACC), 2014 - Present
American Association of Clinical Chemistry, 2016 - 2020
College of American Pathologists, 2018 - 2023
Academy of Clinical Laboratory Physicians and Scientists, 2018 - Present
Society of Young Clinical Laboratorians (SYCL), 2018 - 2022
Clinical Laboratory Standards Institute, 2019 - 2020
ADLM (formerly AACC) Academy, 2019 - Present
International Federation of Clinical Chemistry, 2021 - 2023
Web Links
Selected Publications
AACC Guidance Document on the Clinical Use of Procalcitonin
Chambliss AB, Patel K, Colon-Franco, JM, Hayden J, Katz S, Minejima E, Woodworth A, J Appl Lab Med 8(3): 598-634, 2023
A Spotlight on Disruptors and Innovators
Patel K, Evans S, Lee J, Pamula V, Shah A, Sweeney TE, Tadimety A, Clinical Chemistry 69(3): 216-221, 2023
Implementation of a real-time urine immunoassay for fentanyl detection at a children’s hospital
Kelso K, Qudgley-Martin M, Patel K, Gardner J, Osterhoudt KC, J Med Toxicol 19(112): , 2023
Urine Toxicology Screening: Tetrahydrocannabinol Positivity Patterns at an U.S. Urban Tertiary Care Children’s Hospital.
Unsihuay D, Poventud-Fuentes I, Osterhoudt K, Patel K, PLUGS 2023, 2023
Limited Evidence for Use of a Black Race Modifier in eGFR Calculations: A Systematic Review
Mark A Marzinke, Dina N Greene, Patrick M Bossuyt, Allison B Chambliss, Lauren R Cirrincione, Christopher R McCudden, Stacy E F Melanson, Jaime H Noguez, Khushbu Patel, Asa E Radix , Yemisi Takwoingi, Gabrielle Winston-McPherson, Bessie A Young, Melanie P Hoenig, Clinical Chemistry 68(4): 521-533, 2022, PMID:34927677
Alternative Sample Matrices Supporting Remote Sample Collection during the Pandemic and Beyond
Emily L Gill, Khushbu Patel, Jane A Dickerson, Matthew C Dulik, Russell P Grant, Denise L Heaney, James W Rudge, Clinical Chemistry 68(2): 269-275, 2022, PMID:34927671
Large dose sertraline ingestion associated with a false-positive urine immunoassay for benzodiazepine [abstract]
Bernardo L, Patel K, Chen A, Osterhoudt K, Clin Toxicol, 2022
Oncometabolites and their role in cancer
Emily L. Gill, Khushbu Patel and Dinesh Rakheja, Cancer Biomarkers: Clinical Aspects of Laboratory Determination 5(): 393-505, 2022
Large dose intentional ciprofloxacin ingestion associated with false-positive urine immunoassay for oxycodone and fentanyl [abstract]
Kelly J, Le T, Patel K, Posner J, Osterhoudt K, Clin Toxicol, 2022
Laboratory testing in pediatric cancer patients
Khushbu Patel, William S. Phipps, Hung S. Luu and Dinesh Rakheja, Cancer Biomarkers: Clinical Aspects of Laboratory Determination 5(): 31-58, 2022
